The latest closing stock price for BioNexus Gene Lab as of June 20, 2025 is 2.87.
An investor who bought $1,000 worth of BioNexus Gene Lab stock at the IPO in 2020 would have $699,000 today, roughly 699 times their original investment - a 270.70% compound annual growth rate over 5 years.
The all-time high BioNexus Gene Lab stock closing price was 285.60 on March 03, 2021.
The BioNexus Gene Lab 52-week high stock price is 8.40, which is 192.7% above the current share price.
The BioNexus Gene Lab 52-week low stock price is 2.01, which is 30% below the current share price.
The average BioNexus Gene Lab stock price for the last 52 weeks is 3.59.
An investor who bought $1,000 worth of BioNexus Gene Lab stock at the IPO in 2020 would have $699,000 today, roughly 699 times their original investment - a 270.70% compound annual growth rate over 5 years.
The all-time high BioNexus Gene Lab stock closing price was 285.60 on March 03, 2021.
The BioNexus Gene Lab 52-week high stock price is 8.40, which is 192.7% above the current share price.
The BioNexus Gene Lab 52-week low stock price is 2.01, which is 30% below the current share price.
The average BioNexus Gene Lab stock price for the last 52 weeks is 3.59.